U.S. Medical Plastics Market Size Worth USD 22.06 Billion by 2034 | CAGR: 6.80%

U.S. Medical Plastics Market Size Worth USD 22.06 Billion by 2034 | CAGR: 6.80%


The U.S. medical plastics market size is expected to reach USD 22.06 billion by 2034, according to a new study by Polaris Market Research. The report “U.S. Medical Plastics Market Share, Size, Trends, Industry Analysis Report By Polymer Type (Thermoplastics, Elastomers, Biodegradable Polymers, Others), By Application, By Manufacturing; Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Medical plastics are specialized polymers used in healthcare for their durability, biocompatibility, and sterilization resistance. They are essential in devices such as syringes, IV tubes, surgical instruments, implants, and packaging. A few types of medical plastics include polyethylene (PE), polypropylene (PP), polyvinyl chloride (PVC), and polycarbonate (PC). These materials are chosen for their non-toxicity, flexibility, and ability to withstand harsh sterilization methods like autoclaving or gamma radiation. Medical plastics improve patient safety by reducing infection risks and enabling single-use disposables. They also enhance precision in diagnostic tools and prosthetics. Innovations such as biodegradable plastics and antimicrobial coatings are advancing sustainability and performance.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/us-medical-plastics-market/request-for-sample

The U.S. is a key country in medical plastics, driven by advanced healthcare infrastructure and stringent FDA regulations. American manufacturers produce high-performance plastics for surgical devices, drug delivery systems, and wearable medical tech. Key materials include silicone for implants, PVC for blood bags, and PTFE for catheters. The market is growing due to rising demand for minimally invasive surgeries and home healthcare devices. Major U.S. companies such as DowDuPont, Eastman Chemical, and Saint-Gobain innovate in biocompatible and recyclable plastics. Regulatory standards ensure safety, while R&D focuses on smart plastics with embedded sensors. The U.S. also emphasizes sustainability, with increasing use of recycled and bio-based polymers.

Top of FormU.S. Medical Plastics Market Report Highlights

  • In terms of polymer type, the thermoplastics segment accounted for 71.34% of the U.S. medical plastics market share in 2024 due to their superior versatility, chemical resistance, and ease of processing.
  • The biodegradable polymers segment is projected to register a CAGR of 8.5% from 2025 to 2034 due to increasing focus on sustainability and regulatory pressures to reduce medical waste.
  • Based on application, the medical instruments & devices segment held 56.45% of the U.S. medical plastics market share in 2024 due to high demand for durable, lightweight, and biocompatible materials used in surgical instruments, catheters, prosthetics, and implantable devices.
  • The medical disposables segment is expected to register a CAGR of 7.4% from 2025 to 2034, owing to growing concerns around infection prevention and cost-effective patient care.
  • In terms of manufacturing, the extrusion tubing segment dominated the U.S. medical plastics market, holding 42.78% of revenue share in 2024 due to the increasing need for flexible, biocompatible tubing used in catheters, IV lines, and dialysis equipment.
  • The injection molding is estimated to record a CAGR of 7.0% from 2025 to 2034, owing to its ability to produce complex medical components at scale.
  • A few key market players include Arkema, BASF, Celanese Corporation, Covestro, Dow, DuPont, Eastman Chemical Company, Ensinger, Evonik Industries AG, Lubrizol, RTP Company, SABIC, Solvay, Spectrum Plastics Group, and Teknor Apex.

Polaris Market Research has segmented the market report on the basis of polymer type, application, and manufacturing:

By Polymer Type Outlook (Revenue, USD Billion, 2021–2034)

  • Thermoplastics
    • Polypropylene (PP)
    • Polyvinyl Chloride (PVC)
    • Polyethylene (PE)
    • Polycarbonate (PC)
    • Polyurethane
    • Acrylonitrile Butadiene Styrene (ABS)
    • Others
  • Elastomers
  • Biodegradable Polymers
  • Others

By Application Outlook (Revenue, USD Billion, 2021–2034)

  • Medical Instruments & Devices
  • Medical Disposables
  • Diagnostic Instruments & Tools
  • Others

By Manufacturing Outlook (Revenue, USD Billion, 2021–2034)

  • Extrusion Tubing
  • Injection Molding
  • Compression Molding
  • Others